Recipharm to buy Sanofi contract business, plant

Jun 15, 2018

Swedish CDMO, Recipharm, has struck a deal with Sanofi to buy the French drugmaker’s contract inhalation drug business and plant in the U.K.

Sanofi's Holmes Chapel manufacturing facility is a leading contract manufacturing site in Europe and is home to a team of more than 450 specialist employees. All employees will automatically transfer to Recipharm.

Recipharm will pay about £45 million ($60.2 million) for the 125,000-square meter site near Manchester.

Read the press release

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments